By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

eXoZymes, Inc. (EXOZ)

NASDAQ Currency in USD
$12.50
+$0.74
+6.29%
Last Update: 11 Sept 2025, 19:58
$104.84M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$8.50 - $23.99
52 Week Range

EXOZ Stock Price Chart

Explore eXoZymes, Inc. interactive price chart. Choose custom timeframes to analyze EXOZ price movements and trends.

EXOZ Company Profile

Discover essential business fundamentals and corporate details for eXoZymes, Inc. (EXOZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

13 Nov 2024

Employees

31.00

CEO

Michael Heltzen

Description

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

EXOZ Financial Timeline

Browse a chronological timeline of eXoZymes, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 12 Aug 2025

EPS came in at -$0.28 .

Earnings released on 12 May 2025

EPS came in at -$0.22 .

EXOZ Stock Performance

Access detailed EXOZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run